Intrexon reported $0 in Ordinary Share Capital for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Agenus AGEN:US USD 2.95M 120K
Amgen AMGN:US USD 32.37B 1.03B
Anika Therapeutics ANIK:US USD 146K 0
Arrowhead Research ARWR:US USD 198K 0
AstraZeneca AZN:LN USD 387M 0
Bluebird Bio BLUE:US USD 829K 94K
Bristol Myers Squibb BMY:US USD 292M 0
GlaxoSmithKline GSK:LN GBP 1.35B 0
Heron Therapeutics HRTX:US USD 1.19M 163K
Immunogen IMGN:US USD 2.21M 2K
Karyopharm Therapeutics KPTI:US USD 8K 0
Macrogenics MGNX:US USD 615K 0
Mannkind MNKD:US USD 2.63M 59K
Novartis NOVN:VX USD 878.25M 11.75M
Peregrine Pharmaceuticals PPHM:US USD 62K 0
Rigel Pharmaceuticals RIGL:US USD 173K 0
Sangamo Biosciences SGMO:US USD 1.62M 85K
Veracyte VCYT:US USD 72K 0
Xencor XNCR:US USD 598K 0
Ziopharm Oncology ZIOP:US USD 216K 0